Dexcom's total assets for Q4 2023 were $6.26B, a decrease of -5.03% from the previous quarter. DXCM total liabilities were $4.20B for the fiscal quarter, a -3.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.